References
- Kazmi WH, Kausz AT, Khan S, et al. Anemia: An early complication of chronic renal insufficiency. Am J Kidney Dis. 2001;38:803–812
- Ganz T. Hepcidin – a regulator of intestinal iron absorption and iron recycling by macrophages. Best Prac Res Clin Hematol. 2005;18(2):171–182
- Atanasiu V, Manolescu B, Stoian I. Hepcidin-central regulator of iron metabolism. Eur J Hematol. 2007;78:1–10
- Taes YE, Wuyts B, Boelaert JR, De Vriese AS, Delanghe JR. Prohepcidin accumulates in renal insufficiency. Clin Chem Lab Med. 2004;42:387–389
- Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Am J Hematol. 2006;81:832–7
- Troutt JS, Butterfield AM, Konrad RJ. Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates. J Clin Lab Anal. 2013;27:504–510
- Peters HP, Laarakkers CM, Pickkers P, et al. Tubular reabsorption and local production of urine hepcidin-25. BMC Nephrol. 2013;14:70
- Malyszko J, Malyszko JS, Mysliwiec M. Serum Prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy. Kidney Blood Press Res. 2009;32:235–238
- Nakanishi T, Kuragano T, Kaibe S, Nagasawa Y, Hasuike Y. Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations? Clin Exp Nephrol. 2012;16:819–826
- Zaritsky J, Young B, Wang HJ, et al. Hepcidin – a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1051–10516
- Kato A, Tsuji T, Luo J, Sakao Y, Yasuda H, Hishida A. Association of Prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients. Am J Nephrol. 2008;28:115–121
- Swinkels DW, Wetzels JF. Hepcidin: A new tool in the management of anaemia in patients with chronic kidney disease? Nephrol Dial Transplant. 2008;23:2450–2453
- Canavesi E, Alfieri C, Pelusi S, Valenti L. Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease. World J Nephrol. 2012;1:166–176
- Xue D, He X, Zhou C. Serum hepcidin level correlates with hyperlipidemia status in patients following allograft renal transplantation. Transplant Proc. 2014;46:156–159
- Samouilidou E, Pantelias K, Petras D, et al. Serum Hepcidin Levels Are Associated With Serum Triglycerides and Interleukin-6 Concentrations in Patients With End-Stage Renal Disease. Ther Apher Dial. 2014;18:279–283